Radiation Oncology Market Worth $11.5 Billion By 2027

The global radiation oncology market size is expected to reach USD 11.5 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.3% over the forecast period. Increasing prevalence of cancer is one of the major factors driving the market growth.

Rising technological advancements in radiation therapy is expected to increase the adoption of radiation oncology. For instance, in April 2019, Accuray Incorporated launched Synchrony motion tracking and correction technology for Radixact system. This technology improves dose accuracy and treatment times and is relatively more effective when compared to conventional radiosurgery therapy systems. Such advancements in technology is expected to boost the market growth.

Key players in the market focus on strategic initiatives such as collaborations, new product developments, and acquisitions. For instance, in August 2019, Mevion Medical Systems and C-RAD integrated MEVION S250i Proton Therapy System and C-RAD Catalyst PT. Integration of these products supports seamless workflow throughout the treatment with patient tracking and monitoring from setup through treatment.

Rising adoption of radiotherapy by medical centers and hospitals is expected to drive the market growth. For instance, according to an article published in Seminars in Radiation Oncology in 2017, it is estimated that more than 12,000 additional treatment machines will be required by 2035 in low- and middle-income countries alone. Furthermore, by 2035, China, India, and Brazil are estimated to require over 3,800; 1,200; and 400 additional machines, respectively.

Key initiatives are being undertaken by the U.S. government to facilitate and support R&D in oncology. Cancer Moonshot, RAS Initiative, and NCI Community Oncology Research Program are some of the initiatives undertaken by the U.S. government and are expected to have a positive impact on market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/radiation-oncology-market

Further key findings from the study suggest:

External Beam Radiation Therapy (EBRT) dominated the radiation oncology market in 2019 owing to high availability and penetration of sophisticated diagnostic tools and increase in awareness about available treatment options
Brachytherapy is projected to account for the largest share through the forecast period due to extensive usage of brachytherapy for the treatment of prostate and breast cancer
EBRT emerged as the largest application segment as this therapy is non-invasive and is used for the treatment of prostate, breast, lung, colorectal, head, and neck cancer owing to its ability to treat cancers in inoperable patients
The growth of the 3-D CRT technology segment is attributed to its precise radiation treatment and ability of radiation beams to form the same shape as the tumor at the specific site of cancer
North America dominated the global market in 2019. Presence of major players, reimbursement policies, and developed health infrastructure are the key factors driving the regional market growth
Key players operating in the market include Accuray, Inc.; Nordion (Canada) Inc.; Varian Medical Systems; IsoRay, Inc.; Ion Beam Applications SA; Elekta AB; C.R. Bard, Inc., Mallinckrodt Public Ltd.; Mevion Medical Systems, and NTP Radioisotopes SOC. Ltd.

Medical Devices Reimbursement Market Worth $1169.8 Billion By 2027

The global medical devices reimbursement market size is expected to reach USD 1169.8 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The rising number of regulatory reforms and increasing efforts of healthcare providers to reduce costs and improve the quality of medical equipment are anticipated to propel the market growth. Medical device reimbursement is defined as the payment, a third-party private or public insurer pays to a healthcare provider for the cost incurred while using healthcare equipment.

The major factors fueling market growth are growing dependence on remuneration, increasing prevalence of chronic diseases, and growing preventive care. Rising focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more remuneration share from them. For instance, a fundamental paradigm shift towards incentivizing early diagnosis through remuneration is noticed across developed economies, such as screening for breast cancer.

With the increasing demand for healthcare equipment, the remuneration services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, an increasing number of people pursuing insurance and consolidation of the healthcare system are the major factors fueling the market.

North America held the highest revenue share of about 50.0% in the market in 2019 and is expected to maintain its dominance over the forecast period. Increasing adoption of healthcare devices reimbursement and raising awareness with regards to cost implications are expected to drive the market in the region. In addition, rising demand for healthcare equipment and an increasing number of healthcare centers is expected to drive the market in this region. With increasing chronic diseases, the demand for healthcare equipment is also increasing. As per the National Health Council Report, around 157.0 million people will suffer from multiple chronic conditions until 2020. Due to these reasons, the market is expected to show significant growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-devices-reimbursement-market

Further Key Findings From the Study Suggest:

The private player segment dominated the market with a share of 64.7% in 2019 due to the presence of a large number of private players
The hospitals segment dominated the market with a share of 49.6% over the forecast period due to recent technological developments and high patient footfall requiring the use of healthcare equipment
North America is expected to dominate the market over the forecast period owing to strong reimbursement framework
The market in Asia Pacific is projected to witness rapid growth during the forecast period owing to rising penetration of insurance services in rural and urban areas.

Dental Adhesives And Sealants Market Size Worth $6.1 Billion By 2027

The global dental adhesives and sealants market size is expected to reach USD 6.1 billion by 2027, expanding at a CAGR of 18.9%, according to a new report by Grand View Research, Inc. The high demand for dental restorations, an increase in the geriatric population and road accidents, and the wide product range are expected to propel market growth over the forecast period. In addition, technological advancements in dental materials are also expected to increase adoption, thereby contributing to market growth.

The introduction of advanced dental sealants by market players are anticipated to dominate the market strategies adopted for growth. For instance, 3M introduced ‘Clinpro’ sealant which changes its color from pink to off-white upon exposure to light. This color change technology not only improves the accuracy of sealant placement but also aids in determining the amount to be placed. The user-friendliness of such technologies is expected to increase the usage and demand for thin plastic coatings among dentists.

Furthermore, the increasing influence of social media coupled with globalization has led to the convergence of concepts related to beauty, especially those concerning facial features. This has led to a rise in demand for dental cosmetic procedures such as tooth whitening, tooth bonding, and dental veneers, which is anticipated to support market growth. Furthermore, the rapidly aging population in countries such as Japan, the U.K., Germany, and the U.S. are anticipated to increase the requirement of dentures and related products.

North America accounted for the highest market share in 2019 owing to favorable reimbursement framework, growing prevalence of oral diseases, and high demand for cosmetic dentistry in the country. In addition, the presence of major players in the region also contributed to market growth.

In Asia Pacific, the market is anticipated to witness the highest CAGR over the forecast. The growth of the market in the region is attributed to growing awareness regarding oral health, increasing the aging population, and rising cases of tooth decay due to changing lifestyles.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-adhesives-sealants-market

Further key findings from the report suggest:

By product, the adhesives segment held the largest market share in 2019 owing to high product availability and demand for cosmetic dentistry
Restorative adhesives held the largest market share of 58.0% in terms of revenue in 2019 owing to their broad applications and the presence of a broad product portfolio in the market
The resin-based sealant segment accounted for the largest revenue share in 2019 due to the high adoption of these products among dentists
In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the growing geriatric population and increase in oral health awareness in the region.

Corneal Implants Market Worth $641.41 Million By 2027

The global corneal implants market size is anticipated to reach USD 641.41 million by 2027 registering a CAGR of 6.5%, according to a new report by Grand View Research, Inc. Rising prevalence of corneal diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the major factor driving the market growth.

The gap between demand and supply is also expected to boost the market growth in the long run. Various programs spreading awareness about the importance of corneal donation are also likely to support market growth. Moreover, many European countries are adopting “opt-out” policy for organ donation to meet the growing demand for corneal grafts.

Increasing number of R&D activities related to corneal implants is expected to foster the market growth over the forecast period. Bioengineered cornea, 3D printed cornea, and stem cells therapy are few of the topics gaining attention from the stakeholders.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/corneal-implants-market

Further key findings from the study suggest:

Based on type, human cornea segment held the largest market share in 2019 and is estimated to retain its dominant position throughout the forecast period
Lack of accessibility, shortage of human corneas, and rising number of graft rejection cases are factors expected to drive the segment growth
Based on end user, the hospital segment held the largest market share in 2019 and is expected to have a significant growth rate over the forecast period
North America holds the largest market share in the global market. U.S, is one of the major suppliers of corneal Implant globally
Asia pacific are expected to witness the fastest CAGR over the forecast period due to rising demand for corneal implants in countries, such as China, Indonesia, and Philippines
Endothelial keratoplasty segment is expected to register the fastest CAGR from 2020 to 2027 owing benefits, such as faster and better visual restoration with decreased risk of infection and accidents to the eye surface
Based on application, Fuchs Dystrophy segment held the largest market share in 2019 and is expected to register the fastest CAGR from 2020 to 2027
This growth can be attributed to the factors, such as rising adoption of minimally invasive surgical procedures and high prevalence of the disease

Surgical Light Market Size Worth $2.2 Billion By 2026

The global surgical lights market size is expected to reach USD 2.2 billion by 2026, registering a CAGR of 4.6% during the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for latest technologies to provide patients the best possible care coupled with rising number of surgical procedures around the globe is expected to fuel the growth.

Surgical lights are mainly used in Ambulatory Surgery Centers (ASCs) and hospitals. They are used by surgeons, clinicians, and proceduralists for optimal visualization during a medical procedure. The lights can also be used in emergency rooms, labor and delivery, and examination rooms. A rise in the number of surgeries due to the high prevalence of cardiovascular diseases, neurological disorders, and accidents and trauma cases is anticipated to drive the demand for surgical lights in the forthcoming years. According to a 2016 report of the World Health Organization (WHO), the number of surgeries increased by ~40% from 2004 to 2012.

North America and Europe have led the surgical light market in terms of both the revenue and volume share, owing to the availability of a large number of advanced and progressive healthcare facilities and growing number of ambulatory surgery centers in the regions. In Asia Pacific, the adoption of surgical lights is rising at a significant rate, due to increasing number of well-equipped healthcare facilities in the region.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-lights-market

Further key findings from the study suggest:

Hospitals and ambulatory surgical centers prefer LED surgical lights due to advantages over halogen lights, such as energy-efficiency, less energy consumption, and longer shelf life
Government initiatives for promoting the adoption of energy-efficient surgical lamps in hospitals and ambulatory surgical centers along with increasing R&D efforts for advancements in surgical lights is driving the market
North America dominated the market with the largest revenue share of 38.7% in 2018. This is due to the increasing number of ambulatory surgical centers for outpatient surgical procedures and growing trend for hybrid operating rooms in U.S.
Asia Pacific is expected to witness the fastest CAGR of 6.4% over the forecast period. Improvement of healthcare infrastructure is attributed to the increasing demand for surgical devices, equipment, and accessories
Few of the surgical lights market players are STERIS plc; A-dec Inc.; BihlerMED; CV Medical; SKYTRON; Herbert Waldmann GmbH & Co. KG; Getinge AB; Hill-Rom Services; S.I.M.E.O.N. Medical GmbH & Co. KG; and Integra LifeSciences Corporation

Blood Collection Market Size Worth $13.99 Billion By 2026

The global blood collection market size is expected to reach a value of USD 13.99 billion by 2026, expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. Rising incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period.

According to the World Health Organization, over 41 million individuals that are equivalent to almost 71% of global deaths were caused due to non-communicable diseases in 2018. Cardiovascular diseases registered the highest mortality rates of over 17.9 million followed by cancer that claimed 9 million deaths and respiratory diseases such as chronic obstructive pulmonary disease & asthma claimed over 3.9 million lives in 2017 globally. These facts are indicative of an increase in the incidence of non-communicable diseases, which is expected to fuel market growth.

An increase in the number of road accidents is anticipated to lead to a rise in demand for blood and its components. According to the National Trauma Institute, trauma injuries account for 30% of lives lost globally. The economic burden due to trauma injuries accounts for nearly USD 671 billion in a year. Statistics from the same source indicate that trauma is the number one cause of death from the age of 1 to 46. These facts are indicative of the rising incidence of trauma injuries that require blood collection products for effective treatment.

The growing rate of novel product launches and investments are anticipated to fuel the market growth during the forecast period. For instance, in August 2019, Velano Vascular announced that the company received an investment of USD 10 million from its strategic investor, Intermountain Healthcare for Velano Vascular’s FDA cleared PIVO needle-free blood collection technology.

PIVO device temporarily attaches itself to a peripheral IV catheter that collects the fresh venous sample. This device uses disposable needle-free that caters to lowered risks, improved quality of care, and increased efficiency. Therefore, the use of such novel technologies to avoid painful blood collection methods is expected to fuel market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-collection-market

Further Key Findings from the Study Suggest:

Blood collection tubes witnessed huge demand owing to its increasing usage in diagnostics and blood sampling, thus, generated largest revenue in the year 2018
Treatment application is anticipated to gain significant market share in the near future owing to rising incidence of chronic diseases
The diagnostics application segment held the largest revenue share in 2018, due to the expanding pool of geriatric population and escalating prevalence of infectious & non-communicable diseases
In 2018, the hospitals segment accounted for the largest share in the market due to an upsurge in the incidence of trauma & accidental cases along with growing number of surgical procedures
North America held the largest share of the blood collection market in the year 2018, which can be attributed to the presence of a highly developed healthcare infrastructure and advanced blood collection products.
Some of the key companies include Abbott Laboratories, NIPRO Medical Corp., Becton, Dickinson and Company, Terumo Corp., Medtronic, Qiagen, and FL MEDICAL s.r.l.

Patient Temperature Management Market Worth $5.0 Billion By 2026

The global patient temperature management market size is anticipated to reach a value of USD 5.0 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. A rising number of surgeries is anticipated to accelerate the demand for temperature management devices. For instance, open heart surgeries require lowering down the body heat of patients through blood cooling, which helps reduce the risk of the post and perioperative surgical complications.

With the growing prevalence of cardiac arrest and other chronic cardiac diseases, there is a rising number of surgeries being undertaken. This growth is anticipated to drive the need for patient temperature management, to avoid the adverse effects on the brain. Patient warming systems are also used for cancer patients as adjuncts with chemotherapy and radiation therapy for more effective results. Moreover, in neonatal care, newborns are likely to experience temperature fluctuations and hence, they are kept in incubators to maintain their normal body temperature. The aforementioned factors are driving demand for temperature monitoring devices.

With the rising demand for conventional warming and cooling devices, there is a growing need for modern temperature management systems. The introduction of a wide range of surface warming and cooling systems by major companies is expected to positively impact the market growth during the forecast period. The blood and fluid temperature management devices have also evolved over the years and are applied through a catheter by circulating warm or cool saline in the patients’ body.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/patient-temperature-management-market

Further Key Findings From the Study Suggest:

Patient warming systems led the market in 2018 due to a rise in the number of surgeries, which lower the body temperature of patients due to the use of general anesthesia
Patient cooling systems are anticipated to exhibit a lucrative CAGR over the forecast period due to the introduction of new products like cooling caps and blood and fluid cooling systems
Surgery segment held the largest market share in 2018 due to the increasing number of cardiac and gynecological surgeries across the globe
Operating rooms segment is expected to generate huge revenue due to a large number of surgical procedures being performed and the need for temperature management during these surgeries
In 2018, North America led the patient temperature management market due to rising demand for technologically advanced products in this region
Asia Pacific is expected to showcase lucrative growth over the forecast period, due to increasing sedentary lifestyle resulting in cardiac-related disorders
Some of the major companies operating in the market include Stryker Corporation; ZOLL Medical Corporation; Cincinnati Sub-Zero Products, LLC; Medtronic, Inc.; 3M Company; Bard Medical, Inc.; and The 37Company

Contrast Media Market Size Worth $6.9 Billion By 2027

The global contrast media market size is expected to reach USD 6.9 billion by 2027, exhibiting a CAGR of 3.6% during the forecast period, according to a new report published by Grand View Research, Inc. Increasing burden of chronic diseases is driving the demand for diagnostic imaging procedures which are anticipated to fuel the contrast agents market growth.

The imaging tests such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and x-rays have become an inevitable part of diagnosis for most of the diseases. The large-scale penetration of imaging technology in healthcare has increased the demand for contrast media. Newer contrast agents are constantly being discovered and investigated. Also, the safety of contrast agents for clinical use is under strict scrutiny.

The rapid rise in the use of medical imaging during the last few decades has resulted in a substantial increase in the use of radiologic contrast media. Half of the around 76.0 million computed tomographic and 34.0 million magnetic resonance imaging examinations performed annually include the use of intravenous contrast agents.

Diagnostic imaging modalities are being increasingly used owing to advancements in the underlying technology, ranging from equipment to administration technology. Innovative products such as syringeless injectors help achieve greater accuracy in delivering the right dose of contrast agents as well as reduce wastage. These injectors enable shorter examination time, leading to increased patient throughput. In 2016, the first syringeless injector was launched by Bracco Diagnostics in U.S.for multi-patient use to increase the number of scans performed in a day.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/contrast-media-contrast-agents-market

Further Key Findings from the Study Suggest:

Iodinated contrast media was the largest segment in 2019 and is anticipated to remain dominant over the forecast period as the products have excellent radio-opacity and low toxicity
X-ray/ CT was the largest modality segment in 2019, in terms of revenue share, owing to wide acceptance and cost-efficiency of the techniques
Cardiovascular diseases is projected to witness the fastest growth over the forecast period due to label extensions for ultrasound and X-ray/ CT contrast agents in U.S. For instance, in 2016, the U.S. FDA approved Lumason for use in liver ultrasonography
North America dominated the contrast media/contrast agents market with the largest revenue share of 44.3% in 2019 owing to the presence of well-established healthcare infrastructure and availability of advanced technology
Some of the key players operating in the market are Bayer AG; General Electric Company; Guerbet; Lantheus Medical Imaging, Inc.; Bracco Diagnostic, Inc.; Trivitron Healthcare; nano Therapeutics Pvt. Ltd.; and iMAX

Neurovascular Devices Market Worth $3.9 Billion By 2027

The global neurovascular devices market size is anticipated to reach USD 3.9 billion by 2027, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive procedures, increasing incidence of neurological disorders, and introduction of technologically advanced products are driving the growth of neurovascular devices.

Increasing incidence of neurological conditions such as stroke and brain aneurysm, cerebral artery stenosis, and stroke are fueling the market growth. For instance, according to the Stroke Association, more than 100,000 people suffer from stroke every year in U.K. and stroke costs are up to USD 33.7 billion per year.

Decreased postoperative pain and speedy recovery are leading to increasing adoption of minimally invasive surgeries and triggering growth of R&D in this field. Several key players are investing in R&D for the launch of innovative minimally invasive surgical instruments, especially got the neurovascular diseases. The endovascular coiling used for the treatment of intracranial aneurysm is one of the minimally invasive procedures widely recommended by the physicians.

Furthermore, increasing number of technologically advanced product launches by the key market players are also contributing to the market growth. For instance, in January 2018, CERENOVUS, launched Galaxy G3 mini coil, the softest and smallest embolic finishing coil used in the treatment of hemorrhagic stroke and intracranial aneurysm.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

Further Key Findings from the Study Suggest:

The cerebral embolization and aneurysm coiling devices segment dominated the neurovascular devices market in 2019 owing to increasing demand for minimally invasive procedures and rising incidence of cerebral artery stenosis
Based on therapeutic application, the stroke segment dominated the market in 2019 owing to increasing prevalence of stroke worldwide, awareness initiatives by various government and non-government organizations, and introduction of technologically advanced products
North America dominated the market with the highest revenue share in 2019 owing to increasing prevalence of stroke and brain aneurysm, increasing disposable income, and presence of key players in the region
Some of the major players operating in the market are Medtronic; Microport Scientific Corporation; Penumbra, Inc.; Stryker; Johnson and Johnson Services Inc.; Microvention Inc.; and Codman Neuro

Pediatric Imaging Market Worth $12.2 Billion By 2027

The global pediatric imaging market size is expected to reach USD 12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing incidences of pediatric trauma cases are expected to accelerate the demand for innovative patient screening, which is expected to augment the market growth.

According to the Centers for Disease Control and Prevention (CDC), an estimated 812,000 children aged 17 or below were treated in the U.S. Emergency Department (ED) for concussion or Traumatic Brain Injury (TBI) in 2014. CDC further stated that injuries due to falling accounted for an approximate 49% of all TBI-related ED visits in children. In addition, increasing focus of market players on product development and innovation is expected to drive the market growth. For instance, in June 2019, Carestream Health, Inc. launched a portable Carestream DRX Plus 2530C X-ray detector with cesium iodide technology, which captures minute details of anatomical structures in pediatric patients.

North America accounted for the largest share in 2019 owing to favorable reimbursement policies, faster adoption of innovative imaging modalities, and growing consumer preference toward noninvasive diagnosis. Increasing investments in order to propel technological innovation is expected to augment the pediatric imaging market growth in the region. For instance, in 2018, Bracco Diagnostics Inc. provided a grant of USD 300,000 to Children’s Hospital of Philadelphia (CHOP), to fund research and train technicians to use a new technology of contrast ultrasound. Also, medical coverage is granted by the Children’s Health Insurance Program (CHIP) for pediatric patients in U.S., which covers imaging services, is a major factor propelling the market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/pediatric-imaging-market

Further key findings from the report suggest:

The magnetic resonance imaging modality segment dominated the market owing to high usage in hospital settings and higher recommendations by radiologists due to safety
By application, the orthopedic/ trauma segment is expected to register the highest CAGR due to rising incidence of bone defects in children combined with increasing cases of ED visits related to trauma
By end user, the hospital segment accounted for the largest market share owing to large number of installed systems in hospital settings and direct collaborations of hospitals with market vendors, thereby offering access to novel and advanced imaging systems
Leading players present in the pediatric imaging market include GE Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V. (Royal Philips); Fujifilm Holdings Corporation; Toshiba Medical Systems Corporation; Samsung Electronics Co., Ltd.; Agfa Healthcare; and Carestream Health, Inc.